InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.00%
)
US TECH 100
16,799.60
(
-1.53%
)
Dow Jones
38,460.92
(
0.00%
)
Brent Oil
86.69
(
-0.61%
)
Bitcoin
62,978.38
(
-2.02%
)
Post# of 21472
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Cbdpotential

Send PM Follow Ignore
Followers 271
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Cbdpotential

Re: None

Wednesday, 07/22/2015 1:07:57 PM

Wednesday, July 22, 2015 1:07:57 PM

Post# of 21472
$avxl
'ANAVEX 2-73 showed in 83 percent (10/12) of patients positive cognitive effects during PART A of the study, which consists of a 36-day on-off-on not-yet-optimized dosing regimen to assess bioavailability. At day 36, the amplitude of the cognitive EEG/ERP biomarker P300 increased 38 percent from baseline. Published data suggests that a 38 percent increase is approximately 4 times higher than donepezil (Aricept®), the current standard of care, in the same timeframe.'
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up